MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 24, 2007; DOI: 10.1124/mol.107.034223


0026-895X/07/7104-957-958$20.00
Mol Pharmacol 71:957-958, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Related Article
Right arrow All Versions of this Article:
mol.107.034223v1
71/4/957    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in MolPharm
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bohn, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bohn, L. M.
Perspective

Constitutive Trafficking—More Than Just Running in Circles?

Laura M. Bohn

Departments of Pharmacology & Psychiatry, the Ohio State University College of Medicine, Columbus, Ohio

The CB1 cannabinoid receptors are among the most highly expressed G protein coupled receptors (GPCRs) in the brain. Their activation has been associated with a wide range of behaviors, including cognition, pain perception, drug addiction, and memory consolidation, and they have been pharmaceutically targeted for pain therapies, smoking cessation, and appetite control. The CB1 receptor has been challenging to study at the molecular level given the hydrophobic nature of its lipid-based agonists and difficulties expressing the recombinant cDNA in cellular cultures. Early transfection studies in cell cultures revealed predominantly intracellular localization of the CB1 receptor and it was not clear whether this was the "normal" distribution or whether this was some artifact of the cellular model systems. However, studies of the endogenously expressed CB1 receptors using specific antibodies have shown that the there is usually a distinct intracellular, vesicular localization of the CB1 receptor. Confocal microscopy analysis reveals that the intracellular CB1 receptors are localized to vesicles, which implies that the receptors are "trafficking" or undergoing a continuous cycle of internalization and membrane relocalization. The article by McDonald et al. (p. 976) in this issue of Molecular Pharmacology addresses whether this constitutive trafficking is related to the activation state of the receptor and whether it plays a role in axonal versus somatodendritic receptor localization.


Received January 17, 2007; accepted January 24, 2007

Address correspondence to: Laura M. Bohn, The Ohio State University Medical Center, 333 W 10th Ave, 5184A Graves Hall, Columbus, OH 43210. E-mail: laura.bohn{at}osumc.edu


Related articles in MolPharm:

An Essential Role for Constitutive Endocytosis, but Not Activity, in the Axonal Targeting of the CB1 Cannabinoid Receptor
Neil A. McDonald, Christopher M. Henstridge, Christopher N. Connolly, and Andrew J. Irving
MolPharm 2007 71: 976-984. [Abstract] [Full Text]  






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics